Mithril Capital Management

Mithril Capital Management, established in 2012 and headquartered in Austin, Texas, is a global venture capital firm. It invests in growth-stage companies across various sectors and geographies, with a focus on technology-driven businesses. Mithril partners with innovative teams building transformative and durable companies, often in sectors ripe for disruption. As a Registered Investment Adviser, Mithril takes a long-term approach to investing, providing capital and support to help these companies thrive.

Santiago Iturbe

Principal

Paul Leggett

Managing Director

Ajay Gopal Royan

Co-Founder and Managing General Partner

62 past transactions

Helion

Series F in 2025
Helion Energy, Inc., established in 2013 and based in Redmond, Washington, specializes in designing and manufacturing power generation equipment. The company's core focus is developing fusion engines and technology, with a mission to create the world's first fusion power plant. Helion has successfully tested prototypes like Trenta and is currently advancing its Polaris project. The company's patented plasma accelerator technology enables it to design fusion generators based on magneto-inertial fusion, producing zero-carbon electricity from fusion. This clean energy solution offers low-cost, safe, and environmentally friendly power generation.

GreyOrange

Series D in 2023
GreyOrange is a global company specializing in modernizing order fulfillment through its innovative robotics and artificial intelligence-driven platform. The company's core product, GreyMatter, integrates predictive and real-time data to optimize warehouse operations by coordinating the activities of workers and mobile robots. This dynamic framework allows retailers, warehouse operators, and third-party logistics providers to achieve automated and efficient order fulfillment, enhancing productivity and reducing costs. By focusing on agility and accuracy, GreyOrange enables organizations to meet customer demands effectively while improving the overall work experience for warehouse employees. The company operates in multiple countries, including the United States, Singapore, Germany, Japan, and India, positioning itself as a leader in the fulfillment industry.

Neocis

Series D in 2022
Neocis, Inc. is a Miami-based company that specializes in the development and manufacturing of robotic guidance systems for dental implant procedures. Founded in 2009, Neocis offers Yomi, a precision robotic instrument that aids in the placement of dental implants by integrating computer imagery from CT scans with the surgical planning process. This technology enhances the capabilities of dental surgeons, providing multi-sensory feedback to improve the accuracy and efficiency of procedures. Yomi is designed to facilitate a minimally invasive approach, allowing for quicker surgeries and faster patient recovery. The company’s focus is on collaborating with dental professionals to address surgical challenges and advance patient care through innovative robotics.

Genetesis

Series C in 2022
Genetesis LLC, established in 2013 and based in Mason, Ohio, specializes in designing, developing, and providing biomagnetic imaging solutions for cardiac healthcare. The company's primary product is Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders by visualizing electrical currents of the heart in 3D. Additionally, they offer Faraday Analytical Cloud, a HIPAA-compliant platform managing end-to-end data workflow for their Magnetocardiograph (MCG). Genetesis aims to redefine clinical diagnosis, monitoring, and screening processes for patients at risk of myocardial ischemia and coronary artery disease, using non-invasive, radiation-free methods.

Juno

Series A in 2022
Juno is a cross-border banking platform that aims to give users across the world a high-yield account to grow their savings. Going live in the US, 2Juno is taking a radical approach towards creating an open and global banking system for everyone, regardless of their location or income. Juno was founded in 2019 and is headquartered in Singapore.

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

ForSight Robotics

Series A in 2022
ForSight Robotics is a company focused on advancing ophthalmic surgery through innovative robotic technology. Founded in 2020 and based in Yoqne`am `illit, Israel, the company develops a platform that integrates robotic microsurgery, advanced visualization technologies, and cognitive computing methods. This combination aims to automate surgical procedures that address diseases causing preventable blindness, thereby enhancing surgical precision and cost-effectiveness. By improving the capabilities of surgeons, ForSight Robotics is positioned to transform the landscape of ophthalmic surgeries and contribute to better vision outcomes for patients.

Oma Fertility

Venture Round in 2022
Oma Fertility is a comprehensive fertility clinic that provides a range of fertility care services, including in-vitro fertilization (IVF), egg freezing, embryo transfer, egg donation, sperm donation, and gestational surrogacy. The clinic utilizes advanced technologies, including artificial intelligence, to enhance the selection process of sperm cells for IVF through its proprietary AI microscope, Oma Sperm InSight. By integrating top lab design and technology with personalized care, Oma Fertility aims to make fertility treatments more accessible and affordable for a diverse population. The clinic also collaborates with external partners, such as surrogate agencies and egg and sperm banks, to facilitate a seamless experience for individuals and couples seeking fertility assistance.

GreyOrange

Debt Financing in 2022
GreyOrange is a global company specializing in modernizing order fulfillment through its innovative robotics and artificial intelligence-driven platform. The company's core product, GreyMatter, integrates predictive and real-time data to optimize warehouse operations by coordinating the activities of workers and mobile robots. This dynamic framework allows retailers, warehouse operators, and third-party logistics providers to achieve automated and efficient order fulfillment, enhancing productivity and reducing costs. By focusing on agility and accuracy, GreyOrange enables organizations to meet customer demands effectively while improving the overall work experience for warehouse employees. The company operates in multiple countries, including the United States, Singapore, Germany, Japan, and India, positioning itself as a leader in the fulfillment industry.

GreyOrange

Venture Round in 2022
GreyOrange is a global company specializing in modernizing order fulfillment through its innovative robotics and artificial intelligence-driven platform. The company's core product, GreyMatter, integrates predictive and real-time data to optimize warehouse operations by coordinating the activities of workers and mobile robots. This dynamic framework allows retailers, warehouse operators, and third-party logistics providers to achieve automated and efficient order fulfillment, enhancing productivity and reducing costs. By focusing on agility and accuracy, GreyOrange enables organizations to meet customer demands effectively while improving the overall work experience for warehouse employees. The company operates in multiple countries, including the United States, Singapore, Germany, Japan, and India, positioning itself as a leader in the fulfillment industry.

AiFi

Series B in 2022
AiFi Inc. is a technology company based in Santa Clara, California, that specializes in developing artificial intelligence-based software for cashier-free retail environments. Founded in 2016, AiFi's platform utilizes advanced computer vision and sensor networks to track shoppers as they navigate stores, manage their carts, and process transactions seamlessly. The technology is designed to be adaptable to a variety of store formats and can support operations in spaces up to 10,000 square feet without the need for shelf sensors. This flexibility allows retailers to implement autonomous shopping solutions that enhance customer experiences while providing valuable insights into inventory management and consumer behavior. AiFi partners with numerous global retailers, including ALDI South Group and Carrefour, to create customized shopping experiences that facilitate reliable, contactless operations. The company has established itself as a leader in the autonomous retail space, being recognized for having the highest number of computer vision-powered autonomous stores worldwide.

Ankyra

Series B in 2021
Ankyra is a biotech company focused on developing anchored immunotherapy to enhance cancer treatment. The company's innovative approach addresses the challenges associated with traditional cytokine therapeutics, which often face limitations due to widespread immune activation and toxicity when administered systemically. Ankyra utilizes its Anchored Immunotherapy Platform to create ANK-101, a stable complex that combines a modified IL-12 cytokine with an FDA-approved adjuvant, aluminum hydroxide, which helps to retain the cytokine's potent activity at the tumor site. This localized delivery results in targeted inflammation that activates an anti-tumor immune response while minimizing adverse effects. Ankyra aims to optimize the efficacy and safety of its therapies, ultimately improving treatment outcomes for cancer patients.

Helion

Series E in 2021
Helion Energy, Inc., established in 2013 and based in Redmond, Washington, specializes in designing and manufacturing power generation equipment. The company's core focus is developing fusion engines and technology, with a mission to create the world's first fusion power plant. Helion has successfully tested prototypes like Trenta and is currently advancing its Polaris project. The company's patented plasma accelerator technology enables it to design fusion generators based on magneto-inertial fusion, producing zero-carbon electricity from fusion. This clean energy solution offers low-cost, safe, and environmentally friendly power generation.

BlackSky

Post in 2021
BlackSky is a provider of real-time geospatial intelligence, specializing in high-frequency satellite imagery and analytics. Founded in 2013 and headquartered in Seattle, the company operates a constellation of small satellites in low Earth orbit, designed to capture imagery efficiently and effectively across more than 95 percent of the Earth's populated areas. BlackSky's services cater to a diverse range of industries, including agriculture, forestry, defense, and engineering, as well as governmental entities. Its Spectra AI software platform enhances the value of the data collected by processing insights from both its satellites and third-party sensors, enabling clients to make informed decisions based on accurate and timely information.

Generation Home

Series A in 2021
Generation Home is a new mortgage lender dedicated to making homeownership work better for everyone.

Paxos

Series D in 2021
Paxos, established in 2012 and based in New York, is a regulated financial institution that specializes in blockchain-based solutions for global financial institutions. It operates a blockchain infrastructure platform designed to facilitate the movement, trading, and management of assets between physical and digital forms. Paxos offers services such as custodial services, digital transformation, and fund mobility, enabling enterprises to tokenize, trade, and settle assets efficiently while reducing counterparty risk. The company's strategic approach involves obtaining regulatory designations to access existing financial infrastructure, allowing it to bridge traditional finance with the digital future.

Invivyd

Series C in 2021
Invivyd is a commercial-stage biopharmaceutical company dedicated to developing and commercializing antibody-based therapies aimed at protecting individuals from serious viral infectious diseases, particularly those with pandemic potential. The company focuses on innovative solutions that surpass the natural limits of immunity, starting with its lead product candidates for SARS-CoV-2. Notable among these candidates are ADG20, designed for the treatment and prevention of COVID-19, and VYD222, a monoclonal antibody optimized for enhanced potency and durability of protection. Invivyd's mission centers on delivering effective, long-lasting therapies to safeguard vulnerable populations from the severe repercussions of ongoing viral threats.

Flex Logix

Series D in 2021
Flex Logix is a semiconductor and software company founded in 2014 and based in Mountain View, California. The company specializes in embedding field-programmable gate arrays (FPGAs) of any size within integrated circuits. Its innovative technology allows chips to change their functionality even after shipment, enabling chip designers to reconfigure essential register-transfer levels both within the integrated circuit and across the entire system. Flex Logix generates revenue through a licensing model that includes the delivery of design files and tools, an annual license for its EFLX Compiler for ongoing programming needs, and royalties based on usage.

ForSight Robotics

Seed Round in 2021
ForSight Robotics is a company focused on advancing ophthalmic surgery through innovative robotic technology. Founded in 2020 and based in Yoqne`am `illit, Israel, the company develops a platform that integrates robotic microsurgery, advanced visualization technologies, and cognitive computing methods. This combination aims to automate surgical procedures that address diseases causing preventable blindness, thereby enhancing surgical precision and cost-effectiveness. By improving the capabilities of surgeons, ForSight Robotics is positioned to transform the landscape of ophthalmic surgeries and contribute to better vision outcomes for patients.

Glance

Venture Round in 2020
Glance Digital Experience Private Limited is a technology company based in Bengaluru, India, that specializes in an artificial intelligence-based "screen zero" content delivery platform. Founded in 2019, Glance provides ad-free, personalized visual and interactive content directly to the lock screens of smartphones and other connected devices. The platform has rapidly gained popularity, crossing the 100 million user milestone within just 21 months, making it one of the fastest-growing consumer internet services globally. Glance's services include access to the latest news, entertainment, games, and shopping experiences in multiple languages, enhancing user engagement and simplifying online interactions. In addition to its core platform, Glance acquired Roposo, a well-known Indian short video platform, further expanding its offerings. As a subsidiary of InMobi Group, Glance is supported by notable investors, including Google and Mithril Partners.

Paxos

Series C in 2020
Paxos, established in 2012 and based in New York, is a regulated financial institution that specializes in blockchain-based solutions for global financial institutions. It operates a blockchain infrastructure platform designed to facilitate the movement, trading, and management of assets between physical and digital forms. Paxos offers services such as custodial services, digital transformation, and fund mobility, enabling enterprises to tokenize, trade, and settle assets efficiently while reducing counterparty risk. The company's strategic approach involves obtaining regulatory designations to access existing financial infrastructure, allowing it to bridge traditional finance with the digital future.

Invivyd

Series B in 2020
Invivyd is a commercial-stage biopharmaceutical company dedicated to developing and commercializing antibody-based therapies aimed at protecting individuals from serious viral infectious diseases, particularly those with pandemic potential. The company focuses on innovative solutions that surpass the natural limits of immunity, starting with its lead product candidates for SARS-CoV-2. Notable among these candidates are ADG20, designed for the treatment and prevention of COVID-19, and VYD222, a monoclonal antibody optimized for enhanced potency and durability of protection. Invivyd's mission centers on delivering effective, long-lasting therapies to safeguard vulnerable populations from the severe repercussions of ongoing viral threats.

Neocis

Series D in 2020
Neocis, Inc. is a Miami-based company that specializes in the development and manufacturing of robotic guidance systems for dental implant procedures. Founded in 2009, Neocis offers Yomi, a precision robotic instrument that aids in the placement of dental implants by integrating computer imagery from CT scans with the surgical planning process. This technology enhances the capabilities of dental surgeons, providing multi-sensory feedback to improve the accuracy and efficiency of procedures. Yomi is designed to facilitate a minimally invasive approach, allowing for quicker surgeries and faster patient recovery. The company’s focus is on collaborating with dental professionals to address surgical challenges and advance patient care through innovative robotics.

Treasure

Seed Round in 2020
Treasure Financial Inc., established in 2017 and headquartered in Toronto, Canada, specializes in developing a money management app tailored for children. The app, Treasure Card, is designed to educate kids about money, fostering good financial habits and understanding of key concepts such as saving, budgeting, and the difference between wants and needs. Parents can monitor and control their children's spending, set savings goals, and utilize educational resources within the app. Additionally, Treasure Card offers features like automatic savings and spending limits to help children learn about money management in a secure and controlled environment.

NUVIA

Series B in 2020
Nuvia, Inc. is a semiconductor company specializing in the design and manufacture of silicon chips and microprocessors. Founded in 2019 and headquartered in Santa Clara, California, Nuvia develops high-performance server system-on-chip processors that utilize advanced central processing unit micro-architecture tailored for data centers. The company's innovative chipsets are engineered to enhance computing performance while ensuring power efficiency and scalability, addressing the demands of compute-intensive applications. By focusing on delivering a faster, more energy-efficient, and secure processing experience, Nuvia aims to transform the capabilities of existing data center processors and support the evolving needs of the technology landscape.

Invivyd

Series A in 2020
Invivyd is a commercial-stage biopharmaceutical company dedicated to developing and commercializing antibody-based therapies aimed at protecting individuals from serious viral infectious diseases, particularly those with pandemic potential. The company focuses on innovative solutions that surpass the natural limits of immunity, starting with its lead product candidates for SARS-CoV-2. Notable among these candidates are ADG20, designed for the treatment and prevention of COVID-19, and VYD222, a monoclonal antibody optimized for enhanced potency and durability of protection. Invivyd's mission centers on delivering effective, long-lasting therapies to safeguard vulnerable populations from the severe repercussions of ongoing viral threats.

Glance

Venture Round in 2019
Glance Digital Experience Private Limited is a technology company based in Bengaluru, India, that specializes in an artificial intelligence-based "screen zero" content delivery platform. Founded in 2019, Glance provides ad-free, personalized visual and interactive content directly to the lock screens of smartphones and other connected devices. The platform has rapidly gained popularity, crossing the 100 million user milestone within just 21 months, making it one of the fastest-growing consumer internet services globally. Glance's services include access to the latest news, entertainment, games, and shopping experiences in multiple languages, enhancing user engagement and simplifying online interactions. In addition to its core platform, Glance acquired Roposo, a well-known Indian short video platform, further expanding its offerings. As a subsidiary of InMobi Group, Glance is supported by notable investors, including Google and Mithril Partners.

Neocis

Venture Round in 2019
Neocis, Inc. is a Miami-based company that specializes in the development and manufacturing of robotic guidance systems for dental implant procedures. Founded in 2009, Neocis offers Yomi, a precision robotic instrument that aids in the placement of dental implants by integrating computer imagery from CT scans with the surgical planning process. This technology enhances the capabilities of dental surgeons, providing multi-sensory feedback to improve the accuracy and efficiency of procedures. Yomi is designed to facilitate a minimally invasive approach, allowing for quicker surgeries and faster patient recovery. The company’s focus is on collaborating with dental professionals to address surgical challenges and advance patient care through innovative robotics.

Auris Health

Series E in 2018
Auris Health, Inc. is a medical technology company based in Redwood City, California, that specializes in the development of robotic systems for diagnostic and therapeutic procedures. Founded in 2007, the company is known for its Monarch Platform, which enhances endoscopic procedures by utilizing flexible robotics, advanced imaging technology, and micro-instrumentation. This platform allows for minimally invasive access to the body through natural openings using small cameras and tools, thereby improving patient outcomes and potentially reducing healthcare costs. Additionally, Auris Health is working on a dual-arm microsurgical system designed for ophthalmic surgery, further expanding its focus on innovative robotic solutions for various medical applications. Auris Health operates as a subsidiary of Johnson & Johnson.

GreyOrange

Series C in 2018
GreyOrange is a global company specializing in modernizing order fulfillment through its innovative robotics and artificial intelligence-driven platform. The company's core product, GreyMatter, integrates predictive and real-time data to optimize warehouse operations by coordinating the activities of workers and mobile robots. This dynamic framework allows retailers, warehouse operators, and third-party logistics providers to achieve automated and efficient order fulfillment, enhancing productivity and reducing costs. By focusing on agility and accuracy, GreyOrange enables organizations to meet customer demands effectively while improving the overall work experience for warehouse employees. The company operates in multiple countries, including the United States, Singapore, Germany, Japan, and India, positioning itself as a leader in the fulfillment industry.

Capture2

Series A in 2018
Capture2, Inc. is a technology company founded in 2015 and headquartered in San Diego, California. It specializes in developing Capture2Proposal, a web-based software-as-a-service solution that integrates research, teaming, probability of win analysis, workflow management, and proposal development for government contractors. The platform provides businesses with essential market intelligence and automated analytics, facilitating their pursuit of government contracts. Capture2 serves a diverse clientele, including contractors, value-added resellers, vendors, and original equipment manufacturers that support government initiatives. The company is committed to enhancing access to government opportunities for entities of all sizes, from small veteran-owned firms to large defense contractors, by leveraging its expertise and focus on customer needs in the government contracting sector.

Figure

Series A in 2018
Figure Technologies, Inc. is a fintech company based in San Francisco, California, that specializes in providing innovative consumer financial solutions. Founded in 2018, the company leverages blockchain technology, artificial intelligence, and advanced analytics to offer a range of financial products, including home equity lines of credit, home improvement loans, and home buy-lease back offerings. Figure aims to address consumer needs related to home improvement, debt consolidation, and retirement planning, allowing customers to access capital in as few as five days. Additionally, the company features Provenance, its blockchain platform designed for business applications, further enhancing its service offerings in the financial sector.

Ment.io

Venture Round in 2018
Ment.io Ltd. is a company that operates a web-based decision-making platform designed to enhance the decision-making processes within teams. Founded in 2014 and based in Tel Aviv, Israel, with an additional office in San Francisco, California, the platform enables users to streamline decision-making by managing the entire process from posing questions to facilitating discussions and finalizing decisions. Ment.io targets mid-to-large-sized organizations and growth companies, addressing the challenges teams face in a fast-paced environment where decision-making can be hindered by excessive meetings and fragmented communication. By promoting efficient and credible decision-making, Ment.io aims to empower teams to make confident decisions that drive action and success.

C2FO

Series F in 2018
C2FO is a global on-demand working capital platform that offers fast and flexible access to low-cost capital for nearly 2 million businesses. By utilizing its patented Name Your Rate® technology and a range of working capital solutions, C2FO enables companies to receive payments sooner from large enterprises, thereby unlocking billions in risk-free capital. Founded in 2008 and headquartered in Kansas City, USA, C2FO aims to create a more inclusive financial system by ensuring that all businesses have the necessary capital to thrive. The platform helps clients optimize cash flow by allowing them to negotiate better payment terms with suppliers and customers, thereby empowering enterprises of all sizes to manage their working capital effectively. C2FO has facilitated over $275 billion in funding globally.

Fractyl Health

Series D in 2017
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Auris Health

Series D in 2017
Auris Health, Inc. is a medical technology company based in Redwood City, California, that specializes in the development of robotic systems for diagnostic and therapeutic procedures. Founded in 2007, the company is known for its Monarch Platform, which enhances endoscopic procedures by utilizing flexible robotics, advanced imaging technology, and micro-instrumentation. This platform allows for minimally invasive access to the body through natural openings using small cameras and tools, thereby improving patient outcomes and potentially reducing healthcare costs. Additionally, Auris Health is working on a dual-arm microsurgical system designed for ophthalmic surgery, further expanding its focus on innovative robotic solutions for various medical applications. Auris Health operates as a subsidiary of Johnson & Johnson.

Avitide

Series E in 2017
Avitide, Inc. specializes in the discovery, manufacture, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, the company focuses on developing customized affinity purification products that improve the efficiency and effectiveness of bioprocessing. Avitide's technology enhances the purification of therapeutic proteins, including enzymes, antibodies, gene therapies, and vaccines, by employing rapid development of chromatography resins through chemical synthesis. This advanced platform enables clients to accelerate bioprocess development timelines, mitigate program risks, and achieve predictable commercial scalability while lowering manufacturing costs in both batch and continuous operations.

Classy

Series C in 2016
Classy, Inc., established in 2006 and headquartered in San Diego, California, specializes in developing and operating an online and mobile fundraising platform for nonprofit organizations and social enterprises globally. The company provides an all-in-one solution for crowdfunding, peer-to-peer campaigns, event ticketing, and direct donations, along with branding and customization tools. Classy also offers integrated solutions with Salesforce and dedicated support services. Since 2011, Classy has facilitated tens of millions of donations from over 190 countries, raising over $2 billion for social causes.

Avitide

Series D in 2016
Avitide, Inc. specializes in the discovery, manufacture, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, the company focuses on developing customized affinity purification products that improve the efficiency and effectiveness of bioprocessing. Avitide's technology enhances the purification of therapeutic proteins, including enzymes, antibodies, gene therapies, and vaccines, by employing rapid development of chromatography resins through chemical synthesis. This advanced platform enables clients to accelerate bioprocess development timelines, mitigate program risks, and achieve predictable commercial scalability while lowering manufacturing costs in both batch and continuous operations.

Spaceflight Industries

Series B in 2016
Spaceflight Industries, Inc. is a Seattle-based company that specializes in providing launch and mission management services for satellites. Founded in 1999, it aims to democratize access to space by simplifying the complexities and costs associated with satellite deployment. The company builds, launches, and operates satellites, offering a variety of services that include ground station networks for small satellite missions and innovative satellite infrastructure through its subsidiaries. Spaceflight Industries develops systems for the commercial space industry, including microsatellites, CubeSat and NanoSat bus systems, and a secondary payload system. Additionally, it provides sub-systems such as avionics, solar panels, and dispensers. The company is committed to creating responsive solutions that enable a range of organizations to utilize space technology effectively and affordably.

Partnerize

Series C in 2016
Partnerize is a company that specializes in partnership automation, offering a comprehensive platform designed to enhance business growth through strategic partnerships. Based in New York City with additional offices globally, Partnerize provides a suite of integrated services including discovery, recruitment, optimization, payment, brand safety, and fraud prevention. The platform leverages artificial intelligence to manage the entire partnership marketing lifecycle, from formation to analysis and prediction of future results. This enables clients to build strong relationships, gain detailed market insights, and drive high-margin revenues through efficient online marketing channels. Partnerize is known for its unrivaled service support, including an in-house program that ensures clients have full control over their partnership strategies.

Stem

Series C in 2016
Stem, Inc., founded in 2009 and based in Millbrae, California with operations in Canada, specializes in providing energy storage solutions and software to businesses aimed at managing energy costs. The company offers Athena, a sophisticated software that leverages big data and machine learning to optimize energy usage timing with high precision. Stem also provides subscription-based models that include automated savings, risk protection, sustainable innovation, and solar energy storage solutions. Additionally, the company deploys distributed batteries in commercial and industrial buildings. Stem's approach involves analyzing electricity consumption patterns of various businesses and designing solutions that protect companies from high electricity costs without altering their operational methods. By combining big data, predictive analytics, and energy storage, Stem helps reduce electric costs for businesses and contributes to grid services.

C2FO

Venture Round in 2016
C2FO is a global on-demand working capital platform that offers fast and flexible access to low-cost capital for nearly 2 million businesses. By utilizing its patented Name Your Rate® technology and a range of working capital solutions, C2FO enables companies to receive payments sooner from large enterprises, thereby unlocking billions in risk-free capital. Founded in 2008 and headquartered in Kansas City, USA, C2FO aims to create a more inclusive financial system by ensuring that all businesses have the necessary capital to thrive. The platform helps clients optimize cash flow by allowing them to negotiate better payment terms with suppliers and customers, thereby empowering enterprises of all sizes to manage their working capital effectively. C2FO has facilitated over $275 billion in funding globally.

Helion

Series B in 2016
Helion Energy, Inc., established in 2013 and based in Redmond, Washington, specializes in designing and manufacturing power generation equipment. The company's core focus is developing fusion engines and technology, with a mission to create the world's first fusion power plant. Helion has successfully tested prototypes like Trenta and is currently advancing its Polaris project. The company's patented plasma accelerator technology enables it to design fusion generators based on magneto-inertial fusion, producing zero-carbon electricity from fusion. This clean energy solution offers low-cost, safe, and environmentally friendly power generation.

Fractyl Health

Series C in 2015
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

AppDirect

Series E in 2015
AppDirect, Inc. operates a cloud service commerce platform that facilitates the selling, distribution, and management of cloud-based products and services. The company offers a range of solutions including AppMarket, a white-label marketplace for third-party products; AppBilling, which aims to transform digital engagement; and AppDistribution, enabling users to distribute SaaS applications. Additionally, AppReseller provides an automated portal for managing referral leads and partner commerce. AppDirect also features AppDevices, a secure platform for industrial manufacturers, and AppIdentity, which enhances organizational productivity and security with tools for user management and single sign-on. Other offerings include AppInsights for real-time business KPI dashboards, AppWise for integrated enterprise applications, and AppHelp for assisting service providers in selling and supporting technology services. Founded in 2009 and based in San Francisco, AppDirect serves a diverse clientele, including communications service providers, software companies, and financial services, with additional offices in multiple countries worldwide.

Auris Health

Series B in 2015
Auris Health, Inc. is a medical technology company based in Redwood City, California, that specializes in the development of robotic systems for diagnostic and therapeutic procedures. Founded in 2007, the company is known for its Monarch Platform, which enhances endoscopic procedures by utilizing flexible robotics, advanced imaging technology, and micro-instrumentation. This platform allows for minimally invasive access to the body through natural openings using small cameras and tools, thereby improving patient outcomes and potentially reducing healthcare costs. Additionally, Auris Health is working on a dual-arm microsurgical system designed for ophthalmic surgery, further expanding its focus on innovative robotic solutions for various medical applications. Auris Health operates as a subsidiary of Johnson & Johnson.

C2FO

Series E in 2015
C2FO is a global on-demand working capital platform that offers fast and flexible access to low-cost capital for nearly 2 million businesses. By utilizing its patented Name Your Rate® technology and a range of working capital solutions, C2FO enables companies to receive payments sooner from large enterprises, thereby unlocking billions in risk-free capital. Founded in 2008 and headquartered in Kansas City, USA, C2FO aims to create a more inclusive financial system by ensuring that all businesses have the necessary capital to thrive. The platform helps clients optimize cash flow by allowing them to negotiate better payment terms with suppliers and customers, thereby empowering enterprises of all sizes to manage their working capital effectively. C2FO has facilitated over $275 billion in funding globally.

Classy

Series B in 2015
Classy, Inc., established in 2006 and headquartered in San Diego, California, specializes in developing and operating an online and mobile fundraising platform for nonprofit organizations and social enterprises globally. The company provides an all-in-one solution for crowdfunding, peer-to-peer campaigns, event ticketing, and direct donations, along with branding and customization tools. Classy also offers integrated solutions with Salesforce and dedicated support services. Since 2011, Classy has facilitated tens of millions of donations from over 190 countries, raising over $2 billion for social causes.

AppDirect

Series D in 2015
AppDirect, Inc. operates a cloud service commerce platform that facilitates the selling, distribution, and management of cloud-based products and services. The company offers a range of solutions including AppMarket, a white-label marketplace for third-party products; AppBilling, which aims to transform digital engagement; and AppDistribution, enabling users to distribute SaaS applications. Additionally, AppReseller provides an automated portal for managing referral leads and partner commerce. AppDirect also features AppDevices, a secure platform for industrial manufacturers, and AppIdentity, which enhances organizational productivity and security with tools for user management and single sign-on. Other offerings include AppInsights for real-time business KPI dashboards, AppWise for integrated enterprise applications, and AppHelp for assisting service providers in selling and supporting technology services. Founded in 2009 and based in San Francisco, AppDirect serves a diverse clientele, including communications service providers, software companies, and financial services, with additional offices in multiple countries worldwide.

Partnerize

Series B in 2014
Partnerize is a company that specializes in partnership automation, offering a comprehensive platform designed to enhance business growth through strategic partnerships. Based in New York City with additional offices globally, Partnerize provides a suite of integrated services including discovery, recruitment, optimization, payment, brand safety, and fraud prevention. The platform leverages artificial intelligence to manage the entire partnership marketing lifecycle, from formation to analysis and prediction of future results. This enables clients to build strong relationships, gain detailed market insights, and drive high-margin revenues through efficient online marketing channels. Partnerize is known for its unrivaled service support, including an in-house program that ensures clients have full control over their partnership strategies.

Palantir Technologies

Series I in 2014
Palantir Technologies, established in 2003, specializes in developing data integration and analysis platforms. The company offers two primary products: Palantir Gotham, designed for enterprises to manage, secure, and analyze data, and Palantir Metropolis, focused on quantitative data analysis. Palantir serves a wide range of sectors, including government, defense, finance, healthcare, and others, helping them make sense of large, complex data sets. The company is headquartered in Palo Alto, California.

Fractyl Health

Series B in 2014
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

DoubleDutch

Series D in 2014
DoubleDutch, Inc. is a provider of event management software aimed at enhancing live event experiences for organizers worldwide. Founded in 2010 and headquartered in McLean, Virginia, the company offers a live engagement platform that includes applications, integrations, and performance metrics, allowing event organizers to digitize experiences and optimize engagement. Its solutions encompass online event registration, enabling users to create custom registration pages, manage pre-event activities, and collect attendee data and payments. DoubleDutch serves a diverse clientele, including brands and associations, for various types of events such as corporate meetings, tradeshows, expos, and conferences. The company also operates locations in major cities across the United States, Canada, Europe, and Asia, and is a subsidiary of Cvent, Inc. as of June 2019.

Helion

Seed Round in 2014
Helion Energy, Inc., established in 2013 and based in Redmond, Washington, specializes in designing and manufacturing power generation equipment. The company's core focus is developing fusion engines and technology, with a mission to create the world's first fusion power plant. Helion has successfully tested prototypes like Trenta and is currently advancing its Polaris project. The company's patented plasma accelerator technology enables it to design fusion generators based on magneto-inertial fusion, producing zero-carbon electricity from fusion. This clean energy solution offers low-cost, safe, and environmentally friendly power generation.

Lookout

Series F in 2014
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.

MagForce NT GmbH

Post in 2014
MagForce AG is a medical device company based in Berlin, Germany, specializing in nanotechnology-based cancer treatment. The company has developed NanoTherm therapy, which targets solid tumors by generating localized heat through the activation of superparamagnetic nanoparticles. Its product offerings include NanoTherm, a ferrofluid containing superparamagnetic iron oxide nanoparticles that respond to alternating magnetic fields, and NanoActivator, a device that applies the magnetic field for therapeutic purposes. Additionally, MagForce provides NanoPlan, a software tool that assists in treatment planning using bioheat transfer equations. Founded in 1997, MagForce focuses on innovative solutions to enhance cancer treatment efficacy.

SilverRail

Series C in 2014
SilverRail, established in 2009 and headquartered in London, UK, specializes in digital infrastructure for the rail industry. Its platform connects rail carriers and suppliers with travel distributors, offering a comprehensive customer experience from journey planning to ticketing. This includes inventory management, scheduling, pricing, booking, payment, and administration, facilitating seamless global rail access.

AppDirect

Series C in 2014
AppDirect, Inc. operates a cloud service commerce platform that facilitates the selling, distribution, and management of cloud-based products and services. The company offers a range of solutions including AppMarket, a white-label marketplace for third-party products; AppBilling, which aims to transform digital engagement; and AppDistribution, enabling users to distribute SaaS applications. Additionally, AppReseller provides an automated portal for managing referral leads and partner commerce. AppDirect also features AppDevices, a secure platform for industrial manufacturers, and AppIdentity, which enhances organizational productivity and security with tools for user management and single sign-on. Other offerings include AppInsights for real-time business KPI dashboards, AppWise for integrated enterprise applications, and AppHelp for assisting service providers in selling and supporting technology services. Founded in 2009 and based in San Francisco, AppDirect serves a diverse clientele, including communications service providers, software companies, and financial services, with additional offices in multiple countries worldwide.

Auris Health

Series A in 2014
Auris Health, Inc. is a medical technology company based in Redwood City, California, that specializes in the development of robotic systems for diagnostic and therapeutic procedures. Founded in 2007, the company is known for its Monarch Platform, which enhances endoscopic procedures by utilizing flexible robotics, advanced imaging technology, and micro-instrumentation. This platform allows for minimally invasive access to the body through natural openings using small cameras and tools, thereby improving patient outcomes and potentially reducing healthcare costs. Additionally, Auris Health is working on a dual-arm microsurgical system designed for ophthalmic surgery, further expanding its focus on innovative robotic solutions for various medical applications. Auris Health operates as a subsidiary of Johnson & Johnson.

Lookout

Series E in 2013
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.

C2FO

Series C in 2013
C2FO is a global on-demand working capital platform that offers fast and flexible access to low-cost capital for nearly 2 million businesses. By utilizing its patented Name Your Rate® technology and a range of working capital solutions, C2FO enables companies to receive payments sooner from large enterprises, thereby unlocking billions in risk-free capital. Founded in 2008 and headquartered in Kansas City, USA, C2FO aims to create a more inclusive financial system by ensuring that all businesses have the necessary capital to thrive. The platform helps clients optimize cash flow by allowing them to negotiate better payment terms with suppliers and customers, thereby empowering enterprises of all sizes to manage their working capital effectively. C2FO has facilitated over $275 billion in funding globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.